Privacy & Disclaimer
How we handle the information you share, and the basis on which this site is published.
Regulatory & medical disclaimer
SynBD is an investigational product candidate. It has not been approved, registered or licensed by any regulatory authority, and its safety and efficacy in dementia or any other condition have not been established. Any references on this website to the potential effects of cannabidiol or SynBD describe areas that are the subject of planned or ongoing clinical investigation. They are not claims of therapeutic benefit and must not be read as such.
Nothing on this website constitutes medical advice, a diagnosis, or a recommendation to use any product. It is not directed at patients or consumers seeking treatment. Anyone with health concerns should consult a qualified healthcare professional.
No offer of securities
This website, including the Investor Relations page, is provided for general corporate information only. It does not constitute or form part of any offer, invitation, inducement or solicitation to purchase, subscribe for or otherwise acquire any securities, and no part of it should form the basis of, or be relied on in connection with, any contract or investment decision.
Any potential investment opportunity is communicated only through a separate confidential briefing, made available solely to qualified investors and strategic partners following review, and is subject to the terms set out in that document. Investment in early-stage clinical development carries significant risk, including the risk of total loss of capital.
Privacy notice (PDPA)
SynBD is operated by PureLife Pharma Sdn. Bhd. (Company No. 202301029059 (1522982-X)), the data controller for this website. We respect your privacy and handle personal data in accordance with applicable data-protection law, including the Malaysian Personal Data Protection Act 2010 (PDPA).
What we collect
- Information you submit through our enquiry and Investor Relations forms — such as your name, organisation, role, email address and any message you provide.
- Basic technical information your browser sends when you visit the site.
How we use it
- To respond to your enquiry and, where relevant, to assess and process a request for the confidential briefing.
- To communicate with you about PureLife Pharma and the SynBD program where you have asked us to.
Sharing and retention
We do not sell your personal data. We share it only with our team and professional advisers on a need-to-know basis, and we retain it only as long as necessary for the purposes above or as required by law.
Your rights
You may request access to, correction of, or deletion of your personal data, and you may withdraw consent to further contact at any time. To exercise these rights, email simone@purelife-pharma.com.
This page is a template for PureLife Pharma's review and should be confirmed with the company's legal adviser before publication. Last updated June 2026.
Back to home